Clinical Trials Browser

Phase EARLY_PHASE1 × Niacinamide × 90 days × Clear all

NCT07286318 2026-02-19

A Randomized Controlled Trial of Topical 5% Niacinamide for Skin Cancer Prevention in Transplant Recipients

Phase EARLY_PHASE1 Not yet recruiting

Carcinoma, Basal Cell, Skin Neoplasms, Keratosis, Actinic